Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6698449 | 0.91 | ENPP2 (0.41) | ENPP2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL14756755 | 0.89 | MGLL (0.58) | ENPP2ALDH1A1MGLL | |
| SCHEMBL20221426 | 0.86 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2ATDP1SMN1; SMN2 | |
| SCHEMBL489059 | 0.84 | ENPP2 (0.56) | ENPP2ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL31571588 | 0.81 | MAPT (0.44) | ENPP2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL29581421 | 0.81 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2ATDP1SMN1; SMN2 | |
| SCHEMBL6684 | 0.81 | TTR (0.59) | ENPP2ALDH1A1KDM4EMGLL | |
| SCHEMBL29380260 | 0.81 | TTR (0.59) | ENPP2ALDH1A1KDM4EMGLL | |
| Acetophenone SCHEMBL29152345 | 0.81 | CA4 (0.61) | ENPP2ALDH1A1MEN1KMT2AMGLL | |
| SCHEMBL4323915 | 0.80 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2ATDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1482 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| CN-115959993-B | Synthesis method of 2-aryl propionic acid compound | 山东中医药大学 | 2025-01-07 | — | — | CN | claimed |
| US-12168654-B2 | Pyrimidine derivative containing one deuterium atom and preparation process and use thereof | GUANGDONG LEWWIN PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) | 2024-12-17 | — | — | US | claimed |
| CN-114939172-B | Preparation method of plant polyphenol modified antibiotic nano particles, product and application thereof | 温州医科大学附属第一医院 | 2024-01-26 | — | — | CN | claimed |
| WO-2024016826-A1 | 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF | 杭州市第七人民医院 | 2024-01-25 | — | — | WO | claimed |
| US-11876137-B2 | Field-effect transistor including a metal oxide composite protective layer, and display element, image display device, and system including the field-effect transistor | RICOH COMPANY, LTD. (JP) | 2024-01-16 | — | — | US | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| US-7153898-B2 | Metal oxide sols as nanoscale additives for polymers | APS LABORATORY (US) | 2006-12-26 | — | — | US | claimed |
| WO-2006069087-A2 | PREPARATION OF METAL CHALCOGENIDE NANOPARTICLES AND NANOCOMPOSITES THEREFROM | APS LABORATORY (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060135669-A1 | Preparation of metal chalcogenide nanoparticles and nanocomposites therefrom | APS LABORATORY | 2006-06-22 | — | — | US | claimed |
| US-6955771-B2 | Metal oxide sols as nanoscale additives for polymers | APS LABORATORY (US) | 2005-10-18 | — | — | US | claimed |
| WO-2005035668-A2 | PREPARATION OF METAL NANOPARTICLES AND NANOCOMPOSITES THEREFROM | APS LABORATORY (US) | 2005-04-21 | — | — | WO | claimed |
| US-6838486-B2 | Preparation of metal nanoparticles and nanocomposites therefrom | APS LABORATORY (US) | 2005-01-04 | — | — | US | claimed |
| US-20040242740-A1 | Metal oxide sols as nanoscale additives for polymers | RYANG HONG-SON (US) | 2004-12-02 | — | — | US | claimed |
| US-20040167257-A1 | PREPARATION OF METAL NANOPARTICLES AND NANOCOMPOSITES THEREFROM | APS LABORATORY | 2004-08-26 | — | — | US | claimed |
| US-20040159824-A1 | METAL OXIDE SOLS AS NANOSCALE ADDITIVES FOR POLYMERS | APS LABORATORY | 2004-08-19 | — | — | US | claimed |
| WO-2004063288-A1 | METAL OXIDE SOLS AS NANOSCALE ADDITIVES FOR POLYMERS | APS LABORATORY (US) | 2004-07-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12168654-B2 | Pyrimidine derivative containing one deuterium atom and preparation process and use thereof | DUT, TYMP, DCTD | ENPP2 2946/4885ALDH1A1 3977/4885KDM4E 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.